Abstract:Aim: Ischemia/reperfusion is an initial triggering event that leads to gut-induced acute lung injury (ALI). In this study, we investigated whether hypoxia inducible factor-1 alpha (HIF-1 alpha) played a role in the pathogenesis of lung injury induced by trauma and hemorrhagic shock (T/HS).Methods: Male Wistar rats underwent laparotomy and hemorrhagic shock for 60 min. Sham-shock animals underwent laparotomy but without hemorrhagic shock. After resuscitation for 3 h, the rats were sacrificed. Morphologic changes of the lungs and intestines were examined. Bronchoalveolar lavage fluid (BALF) was collected. Lung water content, pulmonary myeloperoxidase (MPO) activity and the levels of malondialdehyde (MDA), nitrite/nitrate, TNF-alpha, IL-1 beta, and IL-6 in the lungs were measured. The gene expression of pulmonary HIF-1 alpha and iNOS, and HIF-1 alpha transcriptional activity in the lungs were also assessed. The apoptosis in the lungs was determined using TUNEL assay and cleaved caspase-3 expression.Results: Lung and intestinal injuries induced by T/HS were characterized by histological damages and a significant increase in lung water content. Compared to the sham-shock group, the BALF cell counts, the pulmonary MPO activity and the MDA, nitrite/nitrate, TNF-alpha, IL-1 beta, and IL-6 levels in the T/HS group were significantly increased. Acute lung injury was associated with a higher degree of pulmonary HIF-1 alpha and iNOS expression as well as apoptosis in the lungs. Intratracheal delivery of HIF-1 alpha inhibitor YC-1 (1 mg/kg) significantly attenuated lung injury, and reduced pulmonary HIF-1 alpha and iNOS expression and HIF-1 alpha transcriptional activity in the T/HS group.Conclusion: Local inhibition of HIF-1 alpha by YC-1 alleviates the lung injury induced by T/HS. Our results provide novel insight into the pathogenesis of T/HS-induced ALI and a potential therapeutic application.

Research Progress on Attenuating ALI by the Inhibition of HIF-1α Pathway

Hypoxia-Inducible Factor-1: A Potential Target to Treat Acute Lung Injury

Advancement of Pathological Role of Hypoxia-Inducible Factor 1 in Acute Lung Injury

Research progress of signaling pathways in acute lung injury

Inhibition of Hypoxia Inducible Factor-1Α Ameliorates Lung Injury Induced by Trauma and Hemorrhagic Shock in Rats

Inhibition Of Hypoxia Inducible Factor-1 Alpha Ameliorates Lung Injury Induced By Trauma And Hemorrhagic Shock In Rats

Progress in the Mechanism and Therapy Research of ALI/ARDS

SIRT1 in acute lung injury: unraveling its pleiotropic functions and therapeutic development prospects

Angiopoietin-1 in the treatment of acute lung injury

Regulation of hypoxia-inducible factor α in inflammation-associated diseases mediated by innate immune cells

The research status and therapeutic targets of hyperoxia-induced acute lung injury

Dynamic changes of tissue factor pathway inhibitor type 2 associated with IL-1β and TNF-α in the development of murine acute lung injury

Research progress of HDACs and associated inhibitors on regulation of acute lung injury

Translational medicine for acute lung injury

Effects of Nitric Oxide and Nitric Oxide Synthases in Acute Lung Injury

The Role of Histone Deacetylases in Acute Lung Injury—Friend or Foe

[Research Progress of Hypoxia Inducible Factor 1alpha in Hypoxic-Ischemic Injury].

Animal models of infection-induced acute lung injury

Activation of Hypoxia-Inducible Factor-1α Via Succinate Dehydrogenase Pathway During Acute Lung Injury Induced by Trauma/Hemorrhagic Shock.

Signal Pathways And Markers Involved In Acute Lung Injury Induced By Acute Pancreatitis

Pro-resolution of Inflammation: a Potential Strategy for Treatment of Acute Lung Injury/acute Respiratory Distress Syndrome.